Scientists find a way to make disease-causing proteins vulnerable to drugs

Jul 27, 2012 By Bill Hathaway
Illustration by Michael Helfenbein

(Phys.org) -- One of the most daunting challenges facing pharmaceutical scientists today are “undruggable proteins” – the approximately 80% of proteins involved in human disease that do not interact with current drugs.

Yale researchers have identified a novel way to design drugs for these previously inaccessible proteins. The research was published July 26 in the journal Chemistry & Biology.

“There is enormous interest in molecules that can both traverse cell membranes and inhibit interactions between proteins,” said Alanna Schepartz, the Milton Harris '29 Ph.D. Professor of Chemistry, director of the Yale Chemical Biology Institute and senior author of the paper. “Proteins and polypeptides are very good at inhibiting interactions between proteins in a test tube. We have identified a signal that helps these proteins enter the cell.”

Most drugs today are very small molecules and fit snuggly into relatively deep pockets in a protein, usually to inhibit a chemical reaction. But many proteins involved in disease do not perform chemical reactions. Instead they bind to other proteins, or DNA, or RNA. It has proven extremely difficult to design small molecules that inhibit these binding interactions.

Although proteins are used as drugs today, they operate almost exclusively in areas outside the cell, not within the cells where many disease processes originate.

Schepartz and her team identified a molecular signal that allows potentially therapeutic proteins to hitch a ride into cells using vesicles, or small packets of molecular information that fuse with membranes of cells in a process called endocytosis. The signal helps the escape from the vesicle to reach the interior of the cell.

“We are very interested to understand how this release signal works, as it may allow researchers to engineer molecules to follow a prescribed pathway into cell,” Schepartz said.

Other Yale authors are Jacob S. Appelbaum, Jonathan R. LaRochelle, Betsy A. Smith, Daniel M. Balkin and Justin M. Holub.

The research was funded by the National Institutes of Health.

Explore further: New technique reveals immune cell motion through variety of tissues

Related Stories

New proteins inhibit HIV infection in cell cultures

Jul 24, 2012

(Medical Xpress) -- Yale Cancer Center scientists have developed a new class of proteins that inhibit HIV infection in cell cultures and may open the way to new strategies for treating and preventing infection ...

Yale scientists map cell signaling network

Nov 30, 2005

Yale University scientists have mapped, for the first time, the proteins and kinase signaling network that control how cells of higher organisms operate.

Researchers make cell biology quantitative

Oct 20, 2005

Yale researchers have reported a method to count the absolute number of individual protein molecules inside a living cell, and to measure accurately where they are located, two basic hurdles for studying biology ...

Recommended for you

'Global positioning' for molecules

23 hours ago

In everyday life, the global positioning system (GPS) can be employed to reliably determine the momentary location of one en route to the desired destination. Scientists from the Institute of Physical and ...

Cells build 'cupboards' to store metals

Dec 17, 2014

Lawrence Livermore researchers in conjunction with collaborators at University of California (link is external), Los Angeles have found that some cells build intracellular compartments that allow the cell ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.